Trump picks Stanford’s Jay Bhattacharya to lead NIH
Bhattacharya would be in charge of Trump’s bold goals to reform the NIH, which spends billions to fund medical research.
Related Articles
What’s My Risk of Lung Cancer After I Quit Smoking?
You did it, you kicked the habit! (Congrats!) But now that you can proudly call yourself a former smoker, you may be wondering: Has your…
Is Grammarly AI? Notre Dame says yes
The rapid introduction of generative AI has created a wild west of policies at colleges, complicating the use of long-standing editing and writing tools.
PTC Therapeutics discontinues development of ALS drug after trial failure
PTC Therapeutics said on Tuesday it is discontinuing the development of its drug for a type of fatal neurodegenerative disease, as it failed to slow…
Community Health Systems nixes $120M deal to sell 3 hospitals
Franklin, Tennessee-headquartered Community Health Systems said it is evaluating future options for the facilities.
How Chartnote is Revolutionizing Patient Care for Hospitalists
Join Angelina Levy, a dedicated hospitalist, as she shares how Chartnote has transformed her patient documentation process. By using Chartnote, Angelina can …
Trump picks Stanford’s Jay Bhattacharya to lead NIH
Bhattacharya would be in charge of Trump’s bold goals to reform the NIH, which spends billions to fund medical research.
How 3 Health Systems Are Scaling Hybrid & Home-Based Models – MedCity News
Leaders from three health systems — Providence, OSF HealthCare and UMass Memorial Health — detailed how their organizations are maximizing hybrid and home-based care models…
Gideon Hirshfield, FRCP, PhD: Developing Therapies to Address Pruritus in PBC
Hirschfield describes the need for therapies that address itch in PBC and explains what linerixibat, an IBAT inhibitor, may offer for pruritus.
Vaccines
This sheet is about exposure to vaccines in pregnancy and while breastfeeding. This information should not take the place of medical care and advice from…
Russell body typhilitis: An unusual mimicker of malignancy!
Colorectal Russell body lesions are exceedingly rare with only four cases described in literature to date.1 We report here a case of Russell body typhilitis…
